Window of opportunity to enhance EU regulatory systems wide open as EU pharma strategy prioritises stronger EU networks

New IQVIA report points to window of opportunity for the EU… 26 October 2023 The EU is currently reviewing its Pharmaceutical Legislation, and the…
Opinion piece by Christoph Stoller for Friends of Europe 3 June 2021 "Too much at stake in the EU pharma strategy to…
European Parliament report calls for increased use of… 24 November 2021 Open
Now or never: Europe must seize the Pharma Legislation… 7 November 2023 Medicines for Europe, representing the European value-added medicines industry, is…